Related references
Note: Only part of the references are listed.Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations
Fabrizio Carta et al.
CHEMICAL COMMUNICATIONS (2012)
Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
Paul C. McDonald et al.
ONCOTARGET (2012)
Selection of Carbonic Anhydrase IX Inhibitors from One Million DNA-Encoded Compounds
Fabian Buller et al.
ACS CHEMICAL BIOLOGY (2011)
Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors
Yuanmei Lou et al.
CANCER RESEARCH (2011)
Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform II
Anna Di Fiore et al.
CHEMICAL COMMUNICATIONS (2011)
Pazopanib: Clinical development of a potent anti-angiogenic drug
Fabio A. B. Schutz et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis
Fabio Pacchiano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Interfering with pH regulation in tumours as a therapeutic strategy
Dario Neri et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations
Jason Wagner et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Carbonic anhydrase inhibitors: Crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV
Anna Di Fiore et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Carbonic anhydrase inhibitors
Claudiu T. Supuran
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors
Balendu Sankara Avvaru et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
The therapy of kidney cancer with biomolecular drugs
G. Di Lorenzo et al.
CANCER TREATMENT REVIEWS (2010)
Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency
Fabio Pacchiano et al.
CHEMICAL COMMUNICATIONS (2010)
Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain
M. Zatovicova et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Pazopanib
Ronald M. Bukowski et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives
Julia K. J. Ahlskog et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Non-Zinc Mediated Inhibition of Carbonic Anhydrases: Coumarins Are a New Class of Suicide Inhibitors
Alfonso Maresca et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model
Ludwig Dubois et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia
Silvia Pastorekova et al.
BJU INTERNATIONAL (2008)
Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity
Claudiu T. Supuran et al.
EXPERT OPINION ON EMERGING DRUGS (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Carbonic anhydrase inhibitors: Cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides
Isao Nishimori et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Carbonic anhydrase inhibitors as anticonvulsant agents
Anne Thiry et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Carbonic anhydrase inhibitors: Clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue
Jean-Yves Winum et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies
G De Simone et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX
F Abbate et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Protein tyrosine kinase inhibitors as anticancer agents
CT Supuran et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2004)
Anticancer and antiviral sulfonamides
A Scozzafava et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Protein tyrosine kinase inhibitors: new treatment modalities?
D Fabbro et al.
CURRENT OPINION IN PHARMACOLOGY (2002)
Carbonic anhydrase inhibitors: Water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects
A Casini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)